About Me

As co-head of our International Life Sciences & Healthcare group and head of Bird & Bird's Regulatory, Public & Administrative Law group in Brussels, I provide cutting edge strategic and regulatory advice to our life sciences clients and represent them in litigation.

I offer both contentious and non-contentious strategic advice to Belgian and international pharma, biotech and medical devices companies, public bodies and national and European industry associations facing complex regulatory frameworks.

My areas of expertise covers issues relating to life-cycle management, clinical trials and data, data exclusivity, marketing, price and reimbursement authorisations, and e-health together with data protection, distribution and advertising issues. I provide advice to biotech companies on issues regarding Advanced Therapy Medicinal Products as well as the legal and bioethical issues relating to research and use of human cells and tissues. I regularly represent our clients before the nationals jurisdictions as well as before the European Court.

My public and administrative law expertise covers the full range of sub practices in public procurement and related litigation, environmental law, REACH, RoHS, WEES and other Belgian and EU compliance issues.

I hold a law degree from the Vrije Universiteit Brussel (VUB), where I worked for four years as a research assistant, and a degree in public and administrative law from the University of Brussels. Before joining Bird & Bird, I was an expert adviser to the Vice-Prime Minister of Belgium for 3 years.

I speak and publish on life sciences regulatory topics and teach an introduction to Biotech Law at the VUB. I'm also on the board of the Belgian Biotech organisation BIO.BE.


  • Université libre de Bruxelles, LLM, Public and Administrative Law
  • Vrije Universiteit Brussel, Master in Law


  • Balie Brussel Nederlandse Orde van Advocaten (Dutch Speaking Brussels Bar) in 1995
Testimonials Carousel Megaphone


Marc Martens heads a group, who has strong expertise in the use of biological material for therapeutic applications and scientific research.

Legal 500 EMEA 2018

Marc Martens assists a range of leading pharmaceutical clients with regulatory questions including those relating to biobanks, data exclusivity and clinical trials. Clients praise him for being an 'extremely knowledgeable and very smart' lawyer with 'a very strong life sciences practice.'

Chambers Europe 2020

Marc Martens heads the healthcare and life sciences group, which advises biotech, medical devices and pharmaceuticals manufacturers, as well as industry associations.

Legal 500 2017

Latest insights

More Insights
test tubes with coloured liquid

European Health & Pharmaceutical Law Review: First Assessment of the SoHO Proposal for a New Legislation on Blood, Tissues and Cells (The SoHO Regulation)

Jul 04 2023

Read More
Medical syringe

European Commission proposes to change the rules on regulatory data protection for medicines

Jun 16 2023

Read More
Pills on pale blue background

Revamping the European pharmaceutical industry: A closer look at the EU's proposed legislative framework

Apr 28 2023

Read More

What's on TwoBirds TV?

More Videos